140 related articles for article (PubMed ID: 31135382)
1. A Prospective Evaluation of the Reliability and Utility of Quality of Life Measures in Patients With Hepatocellular Carcinoma.
Kim GA; Kim HI; Chang S; An J; Lee D; Lee HC; Han S; Shim JH
Am J Clin Oncol; 2019 Jul; 42(7):555-563. PubMed ID: 31135382
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
[TBL] [Abstract][Full Text] [Related]
3. The association of liver function and quality of life of patients with liver cancer.
Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W
BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18).
Mikoshiba N; Tateishi R; Tanaka M; Sakai T; Blazeby JM; Kokudo N; Koike K; Kazuma K
Health Qual Life Outcomes; 2012 May; 10():58. PubMed ID: 22651810
[TBL] [Abstract][Full Text] [Related]
5. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients.
Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AK; Tang NL; Chu CM; Hui J; Lee KF; Yu S; Yeo W
Qual Life Res; 2019 Sep; 28(9):2597-2607. PubMed ID: 31037590
[TBL] [Abstract][Full Text] [Related]
6. International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18.
Chie WC; Blazeby JM; Hsiao CF; Chiu HC; Poon RT; Mikoshiba N; Al-Kadhimi G; Heaton N; Calara J; Collins P; Caddick K; Costantini A; Vilgrain V; Trinquart L; Chiang C;
Hepatology; 2012 Apr; 55(4):1122-9. PubMed ID: 22105642
[TBL] [Abstract][Full Text] [Related]
7. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
[TBL] [Abstract][Full Text] [Related]
8. Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Klein J; Dawson LA; Jiang H; Kim J; Dinniwell R; Brierley J; Wong R; Lockwood G; Ringash J
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):16-25. PubMed ID: 26279020
[TBL] [Abstract][Full Text] [Related]
9. Role functioning is associated with survival in patients with hepatocellular carcinoma.
Meier A; Yopp A; Mok H; Kandunoori P; Tiro J; Singal AG
Qual Life Res; 2015 Jul; 24(7):1669-75. PubMed ID: 25502092
[TBL] [Abstract][Full Text] [Related]
10. FACT-Hep increases the accuracy of survival prediction in HCC patients when added to ECOG Performance Status.
Gmür A; Kolly P; Knöpfli M; Dufour JF
Liver Int; 2018 Aug; 38(8):1468-1474. PubMed ID: 29389088
[TBL] [Abstract][Full Text] [Related]
11. Psychometric validation of the EORTC QLQ-HCC18 in patients with previously treated unresectable hepatocellular carcinoma.
Serrano D; Podger L; Barnes G; Song J; Tang B
Qual Life Res; 2022 Mar; 31(3):937-950. PubMed ID: 34518988
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
[TBL] [Abstract][Full Text] [Related]
13. Summary scores captured changes in subjects' QoL as measured by the multiple scales of the EORTC QLQ-C30.
Phillips R; Gandhi M; Cheung YB; Findlay MP; Win KM; Hai HH; Yang JM; Lobo RR; Soo KC; Chow PK
J Clin Epidemiol; 2015 Aug; 68(8):895-902. PubMed ID: 25843232
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of the Simplified Chinese Version of EORTC QLQ-HCC18 for Patients with Hepatocellular Carcinoma.
Yang Z; Wan C; Li W; Cun Y; Meng Q; Ding Y; Chen P
Cancer Invest; 2015; 33(8):340-6. PubMed ID: 26046473
[TBL] [Abstract][Full Text] [Related]
15. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
[TBL] [Abstract][Full Text] [Related]
16. The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma.
Diouf M; Filleron T; Barbare JC; Fin L; Picard C; Bouché O; Dahan L; Paoletti X; Bonnetain F
J Hepatol; 2013 Mar; 58(3):509-21. PubMed ID: 23178978
[TBL] [Abstract][Full Text] [Related]
17. Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma.
Diouf M; Bonnetain F; Barbare JC; Bouché O; Dahan L; Paoletti X; Filleron T
Oncologist; 2015 Jan; 20(1):62-71. PubMed ID: 25542450
[TBL] [Abstract][Full Text] [Related]
18. Differences in health-related quality of life between European and Asian patients with hepatocellular carcinoma.
Chie WC; Blazeby JM; Hsiao CF; Chiu HC; Poon RT; Mikoshiba N; Al-Kadhim G; Heaton N; Calara J; Collins P; Caddick K; Costantini A; Vilgrain V;
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e304-e311. PubMed ID: 27038366
[TBL] [Abstract][Full Text] [Related]
19. Quality of life as a prognostic factor for survival in hepatocellular carcinoma.
Sternby Eilard M; Hagström H; Mortensen KE; Wilsgaard T; Vagnildhaug OM; Dajani O; Stål P; Rizell M
Liver Int; 2018 May; 38(5):885-894. PubMed ID: 28941130
[TBL] [Abstract][Full Text] [Related]
20. Depressive symptoms after treatment in hepatocellular carcinoma survivors: prevalence, determinants, and impact on health-related quality of life.
Mikoshiba N; Miyashita M; Sakai T; Tateishi R; Koike K
Psychooncology; 2013 Oct; 22(10):2347-53. PubMed ID: 23686523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
